110167-16-3 Usage
Uses
Used in Organic Synthesis:
4-Benzyl-3-chloromethyl-morpholine is used as an intermediate compound in the synthesis of various organic compounds for [application reason]. Its unique structure allows it to participate in multiple chemical reactions, facilitating the formation of complex molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-Benzyl-3-chloromethyl-morpholine is used as a building block for the development of new drugs, owing to its ability to react with other molecules and form bioactive compounds.
Used in Chemical Research:
4-Benzyl-3-chloromethyl-morpholine is utilized in chemical research as a model compound to study the properties and reactivity of organochlorine and morpholine derivatives, contributing to the advancement of chemical knowledge and the discovery of new applications.
Note: The specific application reasons for the uses listed above are not provided in the materials. The placeholders "[application reason]" should be replaced with the actual reasons based on further information or context.
Check Digit Verification of cas no
The CAS Registry Mumber 110167-16-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,0,1,6 and 7 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 110167-16:
(8*1)+(7*1)+(6*0)+(5*1)+(4*6)+(3*7)+(2*1)+(1*6)=73
73 % 10 = 3
So 110167-16-3 is a valid CAS Registry Number.
InChI:InChI=1/C12H16ClNO/c13-8-12-10-15-7-6-14(12)9-11-4-2-1-3-5-11/h1-5,12H,6-10H2
110167-16-3Relevant academic research and scientific papers
Synthesis and Resolution of 3-Substituted Morpgoline Appetite Suppressants and Chiral Synthesis via O-Arylhomoserines
Brown, George R.,Foubister, Alan J.,Stribling, Donald
, p. 547 - 552 (2007/10/02)
The synthesis and resolution of potential appetite suppressant 3-(2-aryloxyethyl)morpholines is described.Assignment of the absolute configuration of the resolved enantiomers is based on a chiral synthesis from O-phenylhomoserines of known configuration.A